Expert Insights for Health Science Companies

As a global leader in health science M&A, recapitalization, and growth financing strategies, Crosstree has led 100+ transactions for companies at the center of this fast-moving industry.

White Paper

Positioning Biobanking Assets for Maximum Value
Leveraging the Precision Medicine Opportunity for Biobanks.

September 9, 2021

As precision medicine grows, so, too, does demand for biobanking services. In this white paper, learn how to evaluate biobank platforms and develop growth strategies that leverage the market shift towards precision medicine.

Read White Paper
BlueBook

Pharma Services March 2022

ConcertAI has raised $150mm in a round of funding led by Sixth Street Partners North American Science Associates has acquired...

BlueBook

Diagnostics & Tools March 2022

Grenova has received funding from Peloton Equity BillionToOne has received $125mm in funding in a round led by Adams Street...

Deal Insights

Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives

March 24, 2022

BlueBook

Pharma Services February 2022

Definitive Healthcare has acquired Analytical Wizards for $70mm Velocity Clinical Research has acquired Trier Health CenExel Clinical Research has acquired...

View All

We were impressed with the intensity and thoroughness of Crosstree’s preparation. Their team worked tirelessly on analytics and positioning, ultimately giving us the flexibility to efficiently navigate various strategic options involving our business and each of its two divisions. I wouldn’t think twice about using Crosstree again.

Crosstree did an exceptional job with our process. We benefited greatly from their industry knowledge, expansive network, deal expertise and just plain hard work. Most importantly, their bankers demonstrated sterling integrity and always gave us sound advice that resulted in an excellent outcome, despite numerous twists and turns along the way.

Crosstree’s specific knowledge of our market segment allowed them to precisely target potential buyers. Further, Crosstree guided management to the right “value drivers” for each potential buyer, optimally tuning our various presentations, and ultimately driving enhanced valuations during the auction process.

Explore greater market insights and financial possibilities with the leading experts in health science.

Jeff Ellis

Jeff Ellis

Co-Founder & Managing Director
Shane Senior, CFA

Shane Senior, CFA

Co-Founder & Managing Director
Zeke Navar

Zeke Navar

Managing Director
Gordon Ryerson

Gordon Ryerson

Managing Director
Stephen Dirkes

Stephen Dirkes

Managing Director
Lance Converse

Lance Converse

Managing Partner - Crosstree Equity Fund
Roman Margolin

Roman Margolin

Managing Partner - Crosstree Equity Fund
Jason Layton

Jason Layton

Director
Patti-Ann Dresback

Patti-Ann Dresback

Director of Operations
Brian Flood

Brian Flood

Chief of Staff
Alex Despo

Alex Despo

Vice President
Daniel Niswonger

Daniel Niswonger

Vice President
Winston Curteza

Winston Curteza

Associate
Adam Johnston

Adam Johnston

Associate
Cason Searan

Cason Searan

Associate
Jay Sojdehei

Jay Sojdehei

Associate
Navin Buxani

Navin Buxani

Analyst
Frank Harris

Frank Harris

Analyst
Anne Juarez

Anne Juarez

Analyst
Scott Klein

Scott Klein

Analyst
Mat Merchel

Mat Merchel

Analyst
Dominic Stockey

Dominic Stockey

Analyst
Michael Levin

Michael Levin

Manager
Dee Zhao

Dee Zhao

Sr. Consultant
Nicolás Cook

Nicolás Cook

Consultant
Zach Zientarski

Zach Zientarski

Consultant
Andy Kipps

Andy Kipps

Jr. Consultant
Saagar Majethia

Saagar Majethia

Junior Consultant
Ray Lens

Ray Lens

Research Analyst
Kristin Hamlin

Kristin Hamlin

Executive Assistant
Stacey Troxell

Stacey Troxell

Operations Manager
Mark Tuckett

Mark Tuckett

Quality Engineer
Meet Our Experts